|
HALL A |
|
08:30-10:30 |
Session 1
Plenary Session
EVIDENCE FROM THE LAST CLINICAL TRIALS IN DIABETES
Chair: S. Cavalcanti, B.L. Wajchenberg |
|
|
What should we learn from the main prospective trials in diabetes?
P. Home
Should we diagnose diabetes by A1C only?
Pro: P. Aschner
Con: R.A. DeFronzo
PANEL DISCUSSION
G. Fuente, J. Gross, F. Lavalle
|
|
11:00-12:30 |
Session 2
NEUROPATHY GUIDELINES
Chair:
|
|
|
|
|
Session 3
MEET THE PROFESSOR |
|
|
Self and continuous monitoring in T2DM patients
Coordinator: G. Lopez
Professor: V. Commendatore
|
|
|
Session 4
WHICH IS THE MOST IMPORTANT CARDIOVASCULAR RISK IN DIABETES?
Chair: M. de Sereday, J. Wainstein |
|
Lipoprotein disorders
R. Carmena
Shift in blood pressure management
Obesity
S. Klein
|
|
16:30-18:00
|
Session 5
DIFFERENT PHENOTYPES OF DIABETES
Chair: G. Frechtel |
|
LADA: Combination of type 1 and type 2 diabetes
P. Pozzilli
Type 2 diabetes in the young
I. Libman
Type 1 diabetes plus metabolic syndrome
I. D. Escobar
|
|
HALL B |
|
11:00-12:30 |
Session 6
VASCULAR DAMAGE IN DIABETES AND HYPERTENSION
Chair: P. Home |
|
Vasculature in obesity, diabetes and hypertension
Microcirculation window to glomerulus
L. Raij
Hemorheologic factors in DM
R. Lyra
PANEL DISCUSSION
|
|
|
Session 7
MEET THE PROFESSOR |
|
|
Should physicians measure BMI or waist circumference in clinical practice?
Coordinator: S. Schraier
Professor: S. Klein
|
|
|
Session 8
|
|
|
|
16:30-18:00 |
Session 9
NOVEL THERAPY FOR T2D
Chair: J. Mestman |
|
|
Novel mechanisms for the treatment of T2DM
H. Katzeff
Long-acting weekly GLP-1 receptor agonists: How far have we gone?
J. Rosenstock
Alternative route for insulin therapy
P. Raskin
|
|
|
|
HALL C |
|
13:30-14:20 |
Session 10
MEET THE PROFESSOR |
|
|
The metabolic syndrome: Insulin resistance in disguise
Coordinator: M. Bendersky
Professor: R.A. DeFronzo
|
|
|
Session 11
CAUSE OF HYPERTENSION
Chair: |
|
Role of autonomic system
A. Ramirez
Role of angiotensin-renin system
R. Waisman
Shift in diabetic renal disease
PANEL DISCUSSION
|
|
16:30-18:00 |
Session 12
INSULIN THERAPY
Chair: G. Fuente |
|
The issue of intensive diabetes treatment in hospitals
D. Marante
Intensification of insulin treatment in T2D
J. Gross
Safety of modern insulin
D. Russel-Jones |
English
Español
WebStudio.co.il